Status:
COMPLETED
Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Rhinitis Allergic
Eligibility:
All Genders
6+ years
Phase:
PHASE4
Brief Summary
Allow physicians not familiar with anti-leukotriene based therapy to test it
Eligibility Criteria
Inclusion
- Establish diagnosis of mild to moderate chronic asthma and/or allergic rhinitis currently on treatment
- Voluntary acceptance to participate in the study
Exclusion
- Patients with cystic fibrosis
- Patients with known hypersensitivity to singulair or any of its components
- Patients with severe chronic asthma
Key Trial Info
Start Date :
March 18 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 29 2005
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT00380705
Start Date
March 18 2005
End Date
July 29 2005
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.